HETANG Ventures Portfolio Companies Recognized at the 9th All Things Grow Conference in Hangzhou

Apr 25, 2025 22:39 CST Updated 22:39

Reprogenix

Innovative Cell Therapy Developer

Origo Biotechnology

Musculoskeletal Regenerative Medicine Material Developer

On April 24, 2025, the 9th Everything Growth Conference grandly opened at the Hangzhou International Expo Center in Zhejiang, China!This year's conference has been upgraded for the first time to become a science and technology innovation brand event in Zhejiang Province, jointly organized by the Zhejiang Provincial Committee of the China Democratic建国会 (Minjian), Zhejiang Provincial Federation of Industry and Commerce, and the China Investment Development Promotion Association.The conference themed "Striving Forward Amidst the Stream – Sailing Three Thousand Miles Against the Current,"Chen Xiaoping, Standing Committee Member of the National Committee of the Chinese People's Political Consultative Conference (CPPCC), Vice Chairman of the Zhejiang Provincial Committee of the CPPCC, and Director of the Zhejiang Provincial Committee of the China Democratic建国Association; Yao Gaojun, Deputy Secretary of the Hangzhou Municipal Committee of the Communist Party of China and Mayor of Hangzhou; Ke Jixin, Vice Governor of Zhejiang Province, and other leaders attended the conference and delivered speeches.

The conference boasts a luxurious lineup of guests, including various big names in the field of innovation and entrepreneurship within Zhejiang Province, as well as numerous heavyweight guests from within China and abroad.As a cutting-edge exchange platform in the field of innovation and entrepreneurship, the 9th Everything Growth Conference serves innovative Zhejiang, and radiates across China and globally.

Zhejiang Province is the most important business layout area for Hotang Venture Capital outside its Beijing headquarters, and also the preferred location for the transformation of scientific and technological achievements by Hotang Venture Capital.Lotus Pond VenturesSince 2017, three funds have been established in Zhejiang Province (Hangzhou City) with the aim of focusing on technology manufacturing and life health as core investment areas, and the continuous output and industrial implementation in Zhejiang of technology transfer represented by Tsinghua University.Lotus Pond Ventures consistently focuses on the theme of commercializing scientific and technological achievements and early-stage investment in original innovative technologies. Its distinctive feature is the implementation of early-stage technology transfer projects in Zhejiang Province. It has successively invested in dozens of enterprises within Zhejiang and led the facilitation of multiple technology commercialization projects landing in Zhejiang.

The Myriad Growth Conference is a forward-looking and authoritative platform for entrepreneurship, innovation, and venture capital dialogue created by Zhejiang Province.As a leader in scientific and technological innovation development"Barometer": The 2025 "Unicorn (Quasi-Unicorn) Enterprises" list will, for the first time, expand the selection scope from Hangzhou to the entire province and introduce the innovative concept of "Seed Unicorn.", better showcasing Zhejiang Province's achievements in the field of innovation and entrepreneurship. Among them:

Two Hetang Investment Enterprises Enter Zhejiang Province's List, Respectively Future Unicorns——Reprogene Bioscience, Seed Unicorn——Origo Biotechnology；
Two Hetang Investment Enterprises Enter the Hangzhou List, Including a Quasi-Unicorn Enterprise——Hangzhou Reprogenix Bioscience,Inc. and Hangzhou Huijian Technology Co., Ltd.

Reprogennix Bioscience

Hangzhou Reprogenix Bioscience, Inc. is a high-tech enterprise specializing in stem cell regenerative medicine, jointly founded by internationally renowned stem cell reprogramming scientist Professor Hongkui Deng and well-known entrepreneur Dr. Lie Ming Ding. The company focuses on the development of new drugs for islet cell therapy products targeting insulin-dependent diabetes.

Origo Biotechnology

Hangzhou Origo Biotechnology Co., Ltd. is a clinical application-oriented enterprise specializing in the research and development of musculoskeletal regenerative medical materials. It was jointly established by Professor Fan Shunwu's orthopedic team from Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, and the medical device industry.

Huijian Technology

Hangzhou Huijian Technology Co., Ltd. is a multi-omics diagnostic product development company built on a technology platform of high-throughput clinical mass spectrometry and artificial olfactory sensing systems. The company's core products are the colorectal cancer peptide spectrum detection kit for auxiliary diagnosis of colorectal cancer and the配套 mass spectrometer.

That evening, at the annual award ceremony of the Myriad Growth Conference for entrepreneurship and innovation, it was announcedThe lists of 2024 Hangzhou Entrepreneur Figures, 2024 Hangzhou Investor Figures, and 2024 Hangzhou Rising Star Investors aim to recognize the driving forces behind the discovery of unicorn companies. Yu Ke, Investment Director of Hotang Ventures, was awarded the title of "Rising Star Investor."

Lotus Pond Ventures Investment DirectorYu Ke (second from the right)

About Hetang Ventures

Lotus Pond VenturesRestructured in 2014 under the strategic backdrop of promoting the transformation of scientific and technological achievements at Tsinghua University, Hotang Ventures is a professional investment management institution primarily focused on early-stage investments in science and technology innovation enterprises. Hotang Ventures concentrates on key fields such as life sciences, medical devices, information technology, and modern manufacturing. It has long been dedicated to investing in innovative enterprises with core hard technologies, while also specializing in incubating investments from scientific and technological achievements by university and top-tier hospital clinical experts. Currently managing nearly 4 billion yuan in funds, Hotang Ventures has invested in nearly 100 projects, supporting scientists and entrepreneurs with significant research discoveries and technological innovations in implementing "commercial transformations from 0 to 1." At the same time, it consistently adheres to selecting high-barrier "first-of-its-kind technologies" for early-stage investment. With outstanding performance, Hotang Ventures has received honors such as being ranked in the “Top 50 Early-Stage Investment Institutions in China” by The Financing and “Top 50 Best Early-Stage Venture Capital Institutions in China” by ChinaVenture.